Published February 10, 2011 | Version v1
Journal article

The level of claudin-7 is reduced as an early event in colorectal carcinogenesis

  • 1. Department of Cellular and Molecular Medicine, Faculty of Health Science, University of Copenhagen (Denmark)
  • 2. Faculty of Medicine, University of Oslo, Oslo (Norway)
  • 3. Department of Gastroenterological Surgery Oslo University Hospital, Oslo (Norway)
  • 4. Department of Environmental and Health Studies, Telemark University College, Bø (Norway)
  • 5. Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo (Norway)
  • 6. Department of Biology, Faculty of Science, University of Copenhagen, Copenhagen (Denmark)
  • 7. Department of Medical Anatomy, Faculty of Health Science, University of Copenhagen, Copenhagen (Denmark)
  • 8. Department of Pathology, Diagnostic Center, Copenhagen University Hospital, Copenhagen (Denmark)
  • 9. Department of Pathology, Oslo University Hospital, Oslo (Norway)
  • 10. Department of Oncology, Oslo University Hospital, Oslo (Norway)

Description

Compromised epithelial barriers are found in dysplastic tissue of the gastrointestinal tract. Claudins are transmembrane proteins important for tight junctions. Claudins regulate the paracellular transport and are crucial for maintaining a functional epithelial barrier. Down-regulation of the oncogenic serine protease, matriptase, induces leakiness in epithelial barriers both in vivo and in vitro. We found in an in-silico search tight co-regulation between matriptase and claudin-7 expression. We have previously shown that the matriptase expression level decreases during colorectal carcinogenesis. In the present study we investigated whether claudin-7 expression is likewise decreased during colorectal carcinogenesis, thereby causing or contributing to the compromised epithelial leakiness of dysplastic tissue. The mRNA level of claudin-7 (CLDN7) was determined in samples from 18 healthy individuals, 100 individuals with dysplasia and 121 colorectal cancer patients using quantitative real time RT-PCR. In addition, immunohistochemical stainings were performed on colorectal adenomas and carcinomas, to confirm the mRNA findings. A 2.7-fold reduction in the claudin-7 mRNA level was found when comparing the biopsies from healthy individuals with the biopsies of carcinomas (p < 0.001). Reductions in the claudin-7 mRNA levels were also detected in mild/moderate dysplasia (p < 0.001), severe dysplasia (p < 0.01) and carcinomas (p < 0.01), compared to a control sample from the same individual. The decrease at mRNA level was confirmed at the protein level by immunohistochemical stainings. Our results show that the claudin-7 mRNA level is decreased already as an early event in colorectal carcinogenesis, probably contributing to the compromised epithelial barrier in adenomas

Availability note (English)

Available from http://dx.doi.org/10.1186/1471-2407-11-65; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045986

Additional details

Publishing Information

Journal Title
BMC cancer (Online)
Journal Volume
11
Journal Page Range
p. 65
ISSN
1471-2407

Optional Information

Copyright
Copyright (c)2011 Bornholdt et al
Notes
PMCID: PMC3045986; PUBLISHER-ID: 1471-2407-11-65; PMID: 21310043; OAI: oai:pubmedcentral.nih.gov:3045986; licensee BioMed Central Ltd.